2. Anti-infection Metabolic Enzyme/Protease
  3. SARS-CoV Angiotensin-converting Enzyme (ACE)
  4. SARS-CoV-2 Spike receptor binding domain, RBD (371-394)

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) 

Cat. No.: HY-P11464
Handling Instructions Technical Support

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) is a peptide from SARS-CoV-2 spike receptor-binding domain. SARS-CoV-2 spike protein receptor-binding domain binds to ACE2. SARS-CoV-2 Spike receptor binding domain, RBD (371-394) can be used in the research of SARS-CoV-2 infection.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

SARS-CoV-2 Spike receptor binding domain, RBD (371-394)

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) is a peptide from SARS-CoV-2 spike receptor-binding domain. SARS-CoV-2 spike protein receptor-binding domain binds to ACE2. SARS-CoV-2 Spike receptor binding domain, RBD (371-394) can be used in the research of SARS-CoV-2 infection[1].

IC50 & Target[1]

ACE

 

Molecular Weight

2630.94

Formula

C117H176N28O37S2
Sequence

Ser-Ala-Ser-Phe-Ser-Thr-Phe-Lys-Cys-Tyr-Gly-Val-Ser-Pro-Thr-Lys-Leu-Asn-Asp-Leu-Cys-Phe-Thr-Asn
Sequence Shortening

SASFSTFKCYGVSPTKLNDLCFTN
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

SARS-CoV-2 Spike receptor binding domain, RBD (371-394) Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

SARS-CoV-2 Spike receptor binding domain, RBD (371-394)SARS-CoVAngiotensin-converting Enzyme (ACE)SARS coronavirusInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
SARS-CoV-2 Spike receptor binding domain, RBD (371-394)
Cat. No.:
HY-P11464
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.